Skip to nav Skip to content

IDSA Practice Guideline Highlights & Status

Listed below is a summary of 2024, 2025 and 2026 highlights for IDSA guidelines as well as guidelines endorsed by IDSA.

Advertisement

Guideline

Publication Month

Journal
Guidelines Released in 2026

Staphylococcus aureus Bacteremia Consensus Statements

(Joint with ESCMID) (Multi-Part Series)

 9/2026 TBA
Vaccines for Seasonal Respiratory Viruses in the Immunocompromised Update 9/2026 TBA
ACCP Consensus Recommendations for the Use of Prolonged-Infusion Beta-Lactam Antibiotics Among Severely Ill Adult Patients 8/2026 ACCP Journals
Antimicrobial Resistance Update 7/2026 TBA
ACCP Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients 7/2026 ACCP Journals
Prevention of Invasive Aspergillosis in Adult Solid Organ Transplant Recipients 6/2026 TBA
SHEA/SIDP/PIDS/IDSA Guidance for the Knowledge and Skills Required for Antimicrobial Stewardship Leaders 5/2026 Antimicrobial Stewardship & Healthcare Epidemiology
HRS Expert Consensus Statement Update on Cardiovascular Implantable Electronic Device Lead Management and Extraction 4/2026 Heart Rhythm
SCCM Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026 3/2026 Pediatric Critical Care Medicine
SCCM Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 3/2026 Critical Care Medicine
IDSA/PIDS 2026 Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age 2/2026 TBA
ACOG 2026 Maternal Immunization Schedule 2/2026 Obstetrics & Gynecology
AAP Recommended Childhood and Adolescent Immunization Schedule: United States 2026 Policy Statement 2/2026 Pediatrics
Guidelines Released in 2025
AASLD/IDSA Practice Guideline Update on Treatment of Chronic Hepatitis B 11/2025 Hepatology
Vaccines for Seasonal Respiratory Viruses in the Immunocompromised 10/2025 TBA
COVID-19 Treatment and Management (Focused Guideline Update: Baricitinib vs. Tocilizumab) 10/2025 Clinical Infectious Diseases
COVID-19 Treatment and Management (Focused Guideline Update: Outpatient Antivirals) 10/2025 Clinical Infectious Diseases
Group A Streptococcal (GAS) Pharyngitis 10/2025 TBA
Complicated Urinary Tract Infections cUTI: Clinical Guidelines for Treatment and Management 7/2025 TBA
COVID-19 Treatment and Management (Focused Guideline Update: Abatacept) 5/2025 Clinical Infectious Diseases
COVID-19 Treatment and Management (Focused Guideline Update: Infliximab) 5/2025 Clinical Infectious Diseases
SHEA/APIC/IDSA/PIDS Multisociety Position Paper: Raising the Bar - Necessary Resources and Structure for Effective Healthcare Facility Infection Prevention and Control Programs 4/2025 Infection Control & Hospital Epidemiology
SHEA Multisociety Guidance for Sterilization and High-Level Disinfection 4/2025 Infection Control & Hospital Epidemiology
Histoplasmosis Guideline Update (Multi-Part Series: Part 1) 3/2025 IDSA & Clinical Infectious Diseases
COVID-19 Treatment and Management (Focused Guideline Update: Vilobelimab) 2/2025 IDSA & Clinical Infectious Diseases
Drug-Susceptible and Drug-Resistant Tuberculosis (Joint with ATS/ERS/CDC) 1/2025 American Journal of Respiratory and Critical Care Medicine
Guidelines Released in 2024
Primary Care Guidance Update (Joint with HIVMA) 10/2024 Clinical Infectious Diseases
COVID:19 Treatment and Management (Focused Guideline Update: Pemivibart) 8/2024 IDSA & Clinical Infectious Diseases
Antimicrobial Resistance Update 7/2024 IDSA & Clinical Infectious Diseases
Intra-abdominal Infections (Multi-Part Series: Part 1) 6/2024 IDSA & Clinical Infectious Diseases
Lab ID Guidance (Joint with ASM) 3/2024 Clinical Infectious Diseases

Updates to COVID-19 guidelines:

Diagnostics: Serology

 2/2024

IDSA & Clinical Infectious Diseases

 

Listed below is a summary of IDSA guidelines in development. 

Guideline

Publication Date (Estimated)

Journal
Antimicrobial Prophylaxis in Surgery (Joint with ASHP/SHEA/SIS) 2026, Q4 American Journal of Health-System Pharmacy
Diagnosis and Management of HAP/VAP (Joint with ATS) 2026, Q4 Clinical Infectious Diseases
HCV (Joint with AASLD) Ongoing Hepatology
Immunomodulators 2026, Q3 Clinical Infectious Diseases
Strep Pharyngitis (Multi-Part Series) 2026, Q4 (Part 2) Clinical Infectious Diseases
Treatment of Complicated Urinary Tract Infections 2027, Q4 Clinical Infectious Diseases

Updates to COVID-19 Guidelines:

Treatment and Management

 Ongoing IDSA & Clinical Infectious Diseases